The global probiotic market is expected to reach a value of $57.2 billion in 2022.

Research also shows that 60% of consumers acknowledge the link between digestive health and overall health, but only 45% of consumers are actively buying them. The potential for food, beverage and nutraceutical products has never been greater. 

There is growing interest in pursuing ways to treat or reduce the risk of disease by altering the microbiome. There are multiple approaches proposed, but assessment of these approaches requires both pre-clinical and clinical studies, conducted to a standard which is acceptable to both the scientific, institutional and commercial community.

Botanical extracts and bioactives are under investigation in clinical trials as their great potential for natural digestive health benefit grows—especially the possibilities surrounding probiotic combination.